Submitted:
14 July 2023
Posted:
17 July 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
- Develop the Hippocratic hypertension self-care scale
- Examine the reliability of the Hippocratic hypertension self-care scale
- Examine the factorial structure of the Hippocratic hypertension self-care scale
- Assess the structural estimation modeling approach of the Hippocratic hypertension self-care scale with the use of explanatory factor analysis (EFA).
2. Materials and Methods
2.1. Establishment of Face and Content Validity of the Hippocratic Hypertension Self-Care Scale
2.2. Study Population and Data Collection
2.3. Statistics
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet (London, England) 2007, 389(10064), 37–55. [CrossRef]
- Chow, C. K., Teo, K. K., Rangarajan, S., Islam, S., Gupta, R., Avezum, A., Bahonar, A., Chifamba, J., Dagenais, G., Diaz, R., Kazmi, K., Lanas, F., Wei, L., Lopez-Jaramillo, P., Fanghong, L., Ismail, N. H., Puoane, T., Rosengren, A., Szuba, A., Temizhan, A., … PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013, 310(9), 959–968. [CrossRef]
- Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J.. Global burden of hypertension: analysis of worldwide data. Lancet (London, England) 2005, 365(9455), 217–223. [CrossRef]
- Hellenic Health Foundation. HYDRIA. Program and targeted action on the health and nutrition of the Greek population: development and implementation of methodology and documentation.
- Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R., & Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (London, England) 2002, 360(9349), 1903–1913. [CrossRef]
- Turnbull, F., Neal, B., Algert, C., Chalmers, J., Chapman, N., Cutler, J., Woodward, M., MacMahon, S., & Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Archives of internal medicine 2005, 165(12), 1410–1419. [CrossRef]
- Choi, H. Y., Oh, I. J., Lee, J. A., Lim, J., Kim, Y. S., Jeon, T. H., Cheong, Y. S., Kim, D. H., Kim, M. C., & Lee, S. Y.. Factors Affecting Adherence to Antihypertensive Medication. Korean journal of family medicine 2008, 39(6), 325–332. 6. [CrossRef]
- Vallée A, Gabet A, Deschamps V, Blacher J, Olié V. Relationship between Nutrition and Alcohol Consumption with Blood Pressure: The ESTEBAN Survey. Nutrients 2019;11(6):1433. [CrossRef]
- Akbarpour, S., Khalili, D., Zeraati, H., Mansournia, M. A., Ramezankhani, A., Ahmadi Pishkuhi, M., Rostami Gooran, S., & Fotouhi, A.. Relationship between lifestyle pattern and blood pressure - Iranian national survey. Scientific reports 2019, 9(1), 15194. [CrossRef]
- Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J.. Predictive validity of a medication adherence measure in an outpatient setting. Journal of clinical hypertension (Greenwich, Conn.) 2008, 10(5), 348–354. [CrossRef]
- Jank, S., Bertsche, T., Schellberg, D., Herzog, W., & Haefeli, W. E.. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharmacy world & science : PWS 2009, 31(4), 426–431. [CrossRef]
- Chen, Y. J., Chang, J., & Yang, S. Y.. Psychometric Evaluation of Chinese Version of Adherence to Refills and Medications Scale (ARMS) and Blood-Pressure Control Among Elderly with Hypertension. Patient preference and adherence 2020, 14, 213–220. [CrossRef]
- Kim, M. T., Hill, M. N., Bone, L. R., & Levine, D. M.. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Progress in cardiovascular nursing 2020, 15(3), 90–96. [CrossRef]
- Cam, M.O., Arabaci, L.B.. Qualitative and quantitative steps on attitude scale. Turkish J Res Dev Nurs. 2010, 2, 59-71.
- Galanis, P.. Validity and reliability of questionnaires in epidemiological studies. Arch of Hellen Med 2013, 30, 97-110.
- RICKHAM P. P.. HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI. British medical journal 1964, 2(5402), 177. 5402. [CrossRef]
- Powers, B., & Knapp, T.. Dictionary of nursing theory and research. New York: Springer Publishing Company 2005.
- Brink, J., & Wood, J.. Advanced Design in Nursing Research (2nd Edn). California: Sage Publication. 1998. [CrossRef]
| Characteristic | Ν (%) |
|---|---|
| Gender | |
| Male | 91 (45.0) |
| Female | 111(55.0) |
| Age (years)a | 66.9 (11.70) |
| Education Level | |
| Compulsory | 60 (29.7) |
| Intermediate | 60 (29.7) |
| Secondary / University | 82 (40.6) |
| Marital status | |
| Married | 28 (13.9) |
| Divorced / Widower | 163 (80.7) |
| Unmarried | 11 (5.4) |
| Living conditions | |
| Alone | 17 (8.4) |
| Family/relation/other support network | 185 (91.6) |
| Employment status | |
| Employed | 67 (33.2) |
| Unemployed | 88(43.6) |
| Retired | 31 (15.3) |
| Household | 16 (7.9) |
| Characteristic | Ν (%) |
|---|---|
| Damage in target organs | |
| Stroke | 15 (6.6) |
| Stable Angina | 8 (3.5) |
| Unstable Angina | 8 (3.5) |
| Acute Myocardial Infraction | 4 (1.8) |
| Retinopathy | 9 (3.9) |
| Comorbidity | |
| Diabetes mellitus | 87 (43.4) |
| Heart failure | 20 (9.9) |
| Respiratory disease | 106 (52.5) |
| Kidney disease | 3 (1.48) |
| Musculoskeletal disease | 35 (17.3) |
| Classification of hypertension according to ESH | |
| I | 72 (35.6) |
| II | 77 (38.1) |
| III | 29 (14.4) |
| Isolated systolic hypertension | 24 (11.9) |
| Systolic blood pressure(mmHg) | 142 (15.88) |
| Diastolic blood pressure(mmHg) | 86 (10.71) |
| Blood Glycose | 106 (36.6) |
| LDL | 119 (41.6) |
| HDL | 46 (12.7) |
| BMI (kg/m2)a | 22.5 (4.73) |
| Smoking | |
| Yes | 26 (11.4) |
| No | 176 (87.1) |
| Daily alcohol consumption | |
| Yes | 26 (11.4) |
| No | 176 (87.1) |
| ESH: European Society of Hypertension, LDL: low density lipoprotein, HDL: high density lipoprotein, BMI: Body Mass Index | |
| Item | Median | q25 | q75 |
|---|---|---|---|
| Q1 | 4.00 | 3.00 | 4.00 |
| Q2 | 3.00 | 1.00 | 4.00 |
| Q3 | 3.00 | 0.00 | 4.00 |
| Q4 | 3.00 | 0.00 | 4.00 |
| Q5 | 1.00 | 0.00 | 3.25 |
| Q6 | 2.00 | 1.00 | 4.00 |
| Q7 | 2.00 | 1.00 | 2.25 |
| Q8 | 2.00 | 1.75 | 3.00 |
| Q9 | 2.00 | 0.75 | 4.00 |
| Q10 | 0.50 | 0.00 | 3.00 |
| Item | Median | q25 | q75 |
| Q11 | 2.50 | 1.00 | 4.00 |
| Q12 | 2.00 | 1.00 | 3.25 |
| Q13 | 3.50 | 1.00 | 4.00 |
| Q14 | 3.00 | 1.00 | 4.00 |
| Q15 | 4.00 | 0.00 | 4.00 |
| Q16 | 2.00 | 1.00 | 3.00 |
| Item | Median | q25 | q75 |
| Q17 | 4.00 | 1.50 | 4.00 |
| Q18 | 0.00 | 0.00 | 0.00 |
| Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 | Q14 | Q15 | Q16 | Q17 | Q18 | |
| Q1 | 1,000 | |||||||||||||||||
| Q2 | ,331 | 1,000 | ||||||||||||||||
| Q3 | ,191 | ,646 | 1,000 | |||||||||||||||
| Q4 | ,144 | ,634 | ,979 | 1,000 | ||||||||||||||
| Q5 | ,150 | ,383 | ,099 | ,111 | 1,000 | |||||||||||||
| Q6 | ,202 | ,000 | ,005 | -,015 | ,352 | 1,000 | ||||||||||||
| Q7 | ,129 | ,392 | ,360 | ,315 | ,495 | ,410 | 1,000 | |||||||||||
| Q8 | ,292 | ,572 | ,239 | ,223 | ,437 | ,128 | ,531 | 1,000 | ||||||||||
| Q9 | ,152 | ,504 | ,475 | ,490 | ,158 | -,205 | ,177 | ,475 | 1,000 | |||||||||
| Q10 | ,027 | ,000 | -,201 | -,204 | ,141 | ,068 | ,276 | ,313 | ,090 | 1,000 | ||||||||
| Q11 | ,141 | ,082 | -,061 | -,111 | ,181 | ,367 | ,201 | ,318 | -,047 | ,092 | 1,000 | |||||||
| Q12 | ,322 | ,569 | ,491 | ,495 | ,249 | ,122 | ,360 | ,422 | ,579 | -,054 | ,343 | 1,000 | ||||||
| Q13 | -,029 | ,679 | ,486 | ,425 | ,062 | -,134 | ,111 | ,208 | ,192 | -,099 | -,016 | ,203 | 1,000 | |||||
| Q14 | ,316 | ,583 | ,320 | ,254 | ,178 | ,151 | ,326 | ,416 | ,397 | ,088 | ,056 | ,394 | ,552 | 1,000 | ||||
| Q15 | ,182 | ,306 | ,344 | ,250 | ,038 | -,001 | ,280 | ,196 | ,106 | ,047 | ,053 | ,357 | ,438 | ,514 | 1,000 | |||
| Q16 | ,297 | ,128 | -,200 | -,179 | ,315 | ,307 | ,228 | ,471 | ,274 | ,277 | ,470 | ,295 | -,145 | ,079 | -,117 | 1,000 | ||
| Q17 | -,187 | ,270 | ,244 | ,218 | ,042 | -,011 | ,062 | -,095 | -,024 | ,030 | -,327 | -,261 | ,302 | ,107 | ,164 | -,512 | 1,000 | |
| Q18 | -,170 | ,290 | ,294 | ,281 | ,092 | -,034 | ,120 | ,014 | ,195 | -,156 | -,269 | -,187 | ,219 | ,090 | ,004 | -,354 | ,774 | 1,000 |
| Factors | Rotation sums of squared loadings | |||||||||||
| Rescaled loading | Eigenvalues | % of variance | Cumulative variance | Cronbach’s alpha | ||||||||
| Factor 1 | Factor 2 | Factor 3 | Factor 4 | Factor 5 | Factor 6 | Factor 7 | ||||||
| Factor 1 | Question 1 | 0.914 | 0.917 | 0.079 | 0.051 | 0.220 | 0.106 | 0.072 | 0.052 | 67.01 | 67.01 | 0.591 |
| Question 2 | 0.866 | 0.867 | 0.166 | 0.111 | 0.225 | 0.115 | 0.105 | 0.100 | ||||
| Question 3 | 0.878 | 0.887 | 0.018 | 0.108 | 0.250 | 0.087 | 0.094 | 0.064 | ||||
| Question 4 | 0.924 | 0.912 | 0.066 | 0.119 | 0.166 | 0.188 | 0.101 | 0.100 | ||||
| Question 5 | 0.642 | 0.675 | 0.146 | 0.104 | 0.210 | 0.102 | 0.314 | 0.214 | ||||
| Factor 2 | Question 6 | 0.668 | 0.432 | 0.020 | 0.544 | 0.305 | 0.247 | 0.173 | 0.103 | 25.97 | 92.94 | 0.375 |
| Question 7 | 0.695 | 0.238 | 0.362 | 0.157 | 0.162 | 0.437 | 0.516 | 0.416 | ||||
| Question 8 | 0.796 | 0.093 | 0.668 | 0.115 | 0.134 | 0.487 | 0.271 | 0.171 | ||||
| Question 9 | 0.792 | 0.169 | 0.495 | 0.483 | 0.218 | 0.103 | 0.476 | 0.276 | ||||
| Question 10 | 0.583 | 0.093 | 0.477 | 0.494 | 0.085 | 0.073 | 0.301 | 0.100 | ||||
| Question 11 | 0.641 | 0.232 | 0.528 | 0.363 | 0.304 | 0.092 | 0.274 | 0.074 | ||||
| Factor 3 | Question 12 | 0.609 | 0.236 | 0.524 | 0.360 | 0.325 | 0.017 | 0.207 | 0.102 | |||
| Factor 4 | Question 13 | 0.733 | 0.004 | 0.420 | 0.435 | 0.160 | 0.582 | 0.056 | 0.036 | 0.557 | ||
| Question 14 | 0.599 | 0.211 | 0.161 | 0.303 | 0.249 | 0.579 | 0.199 | 0.107 | ||||
| Factor 5 | Question 15 | 0.485 | 0.078 | 0.009 | 0.196 | 0.110 | 0.449 | 0.477 | 0.208 | |||
| Factor 6 | Question 16 | 0.700 | 0.341 | 0.599 | 0.237 | 0.394 | 0.110 | 0.033 | 0.013 | |||
| Factor 7 | Question 17 | 0.851 | 0.252 | 0.041 | 0.497 | 0.704 | 0.174 | 0.113 | 0.103 | 0.807 | ||
| Question 18 | 0.826 | 0.427 | 0.002 | 0.368 | 0.643 | 0.190 | 0.241 | 0.141 | ||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).